In 2024, the global lipid nanoparticle manufacturing market was valued at approximately USD 1.52 billion and is projected to reach USD 4.78 billion by 2032, expanding at a robust CAGR of 15.4% during the forecast period. This strong growth reflects rising investments in biopharmaceutical research, increasing approvals of RNA-based therapies, and expanding manufacturing capacities worldwide.